nt0502
Generic: N-desethyloxybutynin·Code: NRX-101, NT0502
nt0502: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Neos Therapeutics, Inc. (NEOS) | Preclinical |
Get deeper analysis on nt0502
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis